Why the study?
Does preoperative platelet function testing reduce waiting time and predict bleeding risk in CABG patients exposed to clopidogrel?
Does preoperative platelet function testing reduce waiting time and predict bleeding risk in CABG patients exposed to clopidogrel?
Preoperative platelet function testing in CABG patients exposed to thienopyridines can safely reduce waiting times for surgery and identify patients at high risk for perioperative bleeding.
Antiplatelet therapy is widely accepted in the contemporary management of patients with coronary syndromes. Effective platelet inhibition can cause an increased risk of bleeding, which is more evident when patients are referred to surgical coronary revascularization. The cardiac surgeon should be familiar with all new antiplatelet drugs. In this article we compile the latest information about antiplatelet therapy and its impact on cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Brizzio et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: